This website is for UK & Ireland healthcare professionals only

Video

Sylvie's story

Video

Jenny's Story

Importance of Genomic testing

Rapidly identifying the most effective treatment for a patient’s specific cancer mutation is critical to achieving the best possible outcomes. Genomic testing is one of the most effective methods for accurately and swiftly identifying key mutation drivers.8

Read more

Non-Small Cell Lung Cancer

Globally, lung cancer remains the leading cause of cancer-related deaths. Non-small cell lung cancer (NSCLC) accounts for approximately 85% of cases.9
Read more

Small Cell Lung Cancer

Small Cell Lung Cancer (SCLC) is a highly proliferative type of cancer with a strong predisposition for early metastasis.10

  1. Cancer Research UK (2022). Survival for lung cancer https://www.cancerresearchuk.org/about-cancer/lung-cancer/survival (Accessed: Sept 2025).

  2. National Lung Cancer Audit State of the Nation 2025. https://www.natcan.org.uk/reports/nlca-state-of-the-nation-2025-version-2/ (Accessed: Sept 2025).

  3. Brown KF, et al. Br J Cancer. 2018;118.

  4. Bhopal A, et al. Journal of the Royal Society of Medicine. 2019;112(7):269-271.

  5. Corby G, et al. Translational Lung Cancer Research. 2024;13(10):2187-2201.

  6. Figueroa, et al. J Thorac Dis. 2025 Jan 22;17(1):476-486

  7. Su, et al. 2025. J Hematol Oncol. 18:35.

  8. Rudin CM, et al. Nat Rev Dis Primers. 2021;7:3.

SC-GB-03541 I November 2025

Medical information
Medical information

Phone UK: 01344 742579 & Ireland: 01 295 9620

Email: Medinfo.bra@boehringer-ingelheim.com

Business hours: 9am-5pm Mon-Thurs, 9am-4pm Fri

Patient safety and pharmacovigilance
Patient safety and pharmacovigilance

Phone UK: 0800 328 1627 & Ireland: 01 291 3960

Email: Pv_local_uk_ireland@boehringer-ingelheim.com